MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2026-01-03, USNA had -$23,268K decrease in cash & cash equivalents over the period. $8,526K in free cash flow.

Cash Flow Overview

Change in Cash
-$23,268K
Free Cash flow
$8,526K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Depreciation and amortization
    • Borrowings on line of credit
    • Equity-based compensation expens...
    • Others
Negative Cash Flow Breakdown
    • Inventories
    • Repurchase of common stock
    • Payments on line of credit
    • Others

Cash Flow
2026-01-03
Net earnings
11,477
Depreciation and amortization
32,562
Right-of-use asset reduction
7,140
(gain) loss on sale of property and equipment
2,093
Equity-based compensation expense
13,828
Deferred income taxes
-7,133
Inventory write-down
2,679
Impairment
6,967
Inventories
34,685
Prepaid expenses and other assets
-621
Accounts payable
5,204
Other liabilities
-14,218
Net cash provided by (used in) operating activities
22,349
Proceeds from the settlement of net investment hedges
0
Payments for net investment hedge
1,072
Proceeds from acquisition working capital adjustment
865
Payments to acquire businesses, net of cash acquired
0
Proceeds from sale of property and equipment
3,905
Purchases of property and equipment
13,823
Net cash provided by (used in) investing activities
-10,125
Repurchase of common stock
27,507
Borrowings on line of credit
17,600
Payments on line of credit
26,600
Payments related to tax withholding for net-share settled equity awards
2,347
Distributions to redeemable noncontrolling interest
1,749
Payments for contingent consideration
0
Net cash provided by (used in) financing activities
-40,603
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
5,111
Net increase (decrease) in cash, cash equivalents, and restricted cash
-23,268
Cash, cash equivalents, and restricted cash at beginning of period
184,508
Cash, cash equivalents, and restricted cash at end of period
161,240
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Depreciation andamortization$32,562K Equity-based compensationexpense$13,828K Net earnings$11,477K Right-of-use asset reduction$7,140K Impairment$6,967K Accounts payable$5,204K Inventory write-down$2,679K Prepaid expenses andother assets-$621K Net cash provided by(used in) operating...$22,349K Effect of exchange ratechanges on cash, cash...$5,111K Canceled cashflow$58,129K Net increase(decrease) in cash, cash...-$23,268K Canceled cashflow$27,460K Borrowings on line of credit$17,600K Proceeds from sale ofproperty and equipment$3,905K Proceeds fromacquisition working capital...$865K Inventories$34,685K Other liabilities-$14,218K Deferred income taxes-$7,133K (gain) loss on sale ofproperty and equipment$2,093K Net cash provided by(used in) financing...-$40,603K Canceled cashflow$17,600K Net cash provided by(used in) investing...-$10,125K Canceled cashflow$4,770K Repurchase of common stock$27,507K Payments on line of credit$26,600K Payments related to taxwithholding for net-share...$2,347K Distributions to redeemablenoncontrolling interest$1,749K Purchases of property andequipment$13,823K Payments for netinvestment hedge$1,072K

USANA HEALTH SCIENCES INC (USNA)

USANA HEALTH SCIENCES INC (USNA)